go to moneycontrol.com
Quote 
NAV 
News 
Messages  
Opinions 
Notices 
[+] SHOW
Glenmark Pharma Homepage >> Moneycontrol.com >> Stocks >> Glenmark >> Pharmaceuticals >> Price/Quote, Highs, Lows, Volumes, Graphs, Bid, Offers, Historic Prices, Financials, Income, Results, Mutual Funds, Background, Management, News, Views, Actions, Interviews, Messages
Glenmark Pharma (BSE: 532296 | NSE: GLENMARK | ISIN: INE935A01035)
659.90 -9.95 (-1.49%)
BSE : Jul 24, 15:57
657.50 -13.40 (-2%)
NSE : Jul 24, 16:01
Open 664.00 Vol 51,025
Prev. Close 669.85
Intraday 52 Week
Highs 674.85 792.00
Lows 644.60 350.00
Open 660.10 Vol 121,487
Prev. Close 670.90
Intraday 52 Week
Highs 682.00 778.00
Lows 643.15 291.05
BID OFFER
Price 666.10 668.00
Quantity 546.00 5.00
BID OFFER
Price 657.50 0.00
Quantity 3,474.00 0.00
Mkt Cap 16,504.57 | * P/E 42.43 | Div 40.00 | * EPS (TTM) 15.55 | B/V: 33.59
Mkt Lot 1.00 | FV 1.00 | * EPS: As per stand alone adjusted profit after extra-ordinary items
Historic Prices & Returns of Glenmark Compare Price Performance With Peers
Price 1 week 2 week 1 month 3 month 6 month 9 month 1 year
BSE / NSE
598.75 599.05 640.35 595.10 500.90 460.95 354.73
10.21% 10.16% 3.05% 10.89% 31.74% 43.16% 86.03%
Gain/Loss
On :
1 Week 1 Month 3 Month 1 Year 2 Year 3 Year
Historic Graph of Glenmark
From : To :
This page Auto Refreshes every 5 minutes
Messages Add to:
News on Glenmark
18-07 Glenmark Pharmaceuticals Ltd has informed BSE that a meeting...
15-07 Glenmark’s molecule GRC 10693 to enter Phase I trials
Views on Glenmark

No Views in the last 7 days

Action on Glenmark
21-07 Glenmark Pharma continues to gain
27-06 Glenmark Pharma in good health
Interviews on Glenmark
09-07 Earnings season to be good for pharma sector this quarter  
on Glenmark
Buy, Sell or Hold?- 66 opinions
3 boarder queriesAnswer now
Have a tip or opinion? Post your view

Messages on Glenmark
                  
No messages in the last 7 days
View Messages :
7 days to 3 months | 3 to 9 months | > 9 months
To Post a new message Click here
BSE/NSE Notices - Glenmark
Financials of Glenmark Quarterly Annual
Income Statement (Mar '08) (Mar '07)
Net Sales 396.90 809.79
Other Income 15.01 18.24
PBDIT 130.47 233.64
Net Profit 130.14 134.80
Profit & Loss | Half Yearly Results | Quarterly Results |
Dividends | Bonus | Rights | Splits | Locations
Balance Sheet
Total Share Capital 24.01
Net Worth 450.16
Total Debt 907.48
Net Block 276.92
Investments 139.10
Net Current Assets 785.34
Total Assets 1357.66
Balance Sheet | Finished Goods | Raw Materials
Mutual Funds Holding - Glenmark
Scheme Name No. of shr
1,585,778
403,732
363,483
358,873
348,927
Are MFs buying or dumping Glenmark
Are fund managers betting on Pharmaceuticals sector
Groups: Pharmaceuticals
Company Last Price Market Cap
1,463.10 30,303.20
231.75 18,013.73
466.70 17,419.01
639.00 10,754.20
1,084.15 9,183.08
Compare with its peer group stocks on
Price Market Cap. Net Sales
Net Profit Total Assets
Simple Moving Averages
Days BSE NSE
30 640.22 639.94
50 646.09 646.32
150 570.66 571.07
200 546.16 546.48
Has Glenmark made any Bar Patterns today?
Has Glenmark made any Candlestick Patterns today?
Company Facts - Glenmark
Registered Address
B/2, Mahalaxmi Chambers
22, Bhulabhai Desai Road
Mumbai
Maharashtra
400026
Tel : 022-56549999
Fax : 022-23512177/23519652
Email : webmaster@glenmarkpharma.com
Website :
http://www.glenmarkpharma.com
Registrars
Karvy Computershare Private Ltd "Karvy House"
46, Avenue 4,
Street No. 1
Banjara Hills
Tel : 23312454, 23320251/751/752
Fax : 23311968
Email : mailmanager@karvy.com
Website :
www.karvy.com
 Intra Day Block Deals | Research Reports | Company Background | Listing Info
 Search all bulk deals in Glenmark Pharma
Management - Glenmark
Gracias Saldanha Non Executive Chairman
Glenn Saldanha Managing Director
A S Mohanty Director
Rajesh V Desai Director
B E Saldanha Director
J F Ribeiro Director
N B Desai Director
Cheryl Pinto Director
M Gopal Krishnan Director
Sridhar Gorthi Director
Type
S Glenmark
SMS to 52622 you
will receive the latest quote on both BSE & NSE.
Announcements
Board Meetings
AGM/EGM
Bonus
Rights
Splits
Dividends
Information
Company History
Background
Board of Directors
Capital Structure
Listing Info
Locations
Bulk Deals
Financials
Balance Sheet
Profit & Loss
Quarterly Results
Half Yearly Results
Nine Monthly Results
Yearly Results
Cash Flow
Annual Report
Directors Report
Chairman's Speech
Auditors Report
Notes to Accounts
Finished Goods
Raw Materials
Peer Comparison
Price
Price Performance
Market Cap
Net Sales
Net Profit
Total Assets
Related links